Company: REVB
Filing Date: 2025-05-23
Form Type: S-1/A
Source: 0001213900-25-047104
Chunk: 90

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-05-23
Form: S-1/A
Chunk 90
---
2024 and the three months ended March 31, 2025 have been prepared on the basis that we will continue as a going concern, and do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the possible inability for us to continue as a going concern. Cash Flows The following table summarizes our cash flows for the periods presented:

|                                                      |     | Three Months 
 Ended March, 
 2025         |            |   |     | 2024 |            |   |     | Year Ended   
 December 31, 
 2024         |             |   |     | 2023 |            |   |
|:-----------------------------------------------------|:----|:-------------|:-----------|:--|:----|:-----|-----------:|:--|:----|:-------------|------------:|:--|:----|:-----|-----------:|:--|
| Net cash used in operating activities                |     | $            | (2,794,407 | ) |     | $    | (2,837,969 | ) |     | $            | (18,321,276 |   |     | $    | (7,286,286 | ) |
| Net cash used in investing activities                |     |              | -          |   |     |      |    (19,172 | ) |     |              |     (19,171 | ) |     |      |          - |   |
| Net cash provided by financing activities            |     |              | -          |   |     |      |  5,417,180 |   |     |              |  12,847,764 |   |     |      | 14,025,008 |   |
| Net (decrease) increase in cash and cash equivalents |     |              | (2,794,407 | ) |     |      |  2,560,039 |   |     |              |  (5,492,683 | ) |     |      |  6,738,722 |   |

Net Cash Used in Operating Activities During the year ended December 31, 2024, net cash used in operating activities was $18.3 million, which consisted of a net loss of $15.0 million and a net change of $3.4 million in our net operating assets and liabilities. During the year ended December 31,